ADENOSQUAMOUS CELL CARCINOMA

ADENOSQUAMOUS CELL CARCINOMA was reported 18 times

ADENOSQUAMOUS CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOPOTECAN 3 0.0005
1 AFATINIB 3 0.0005
2 FRUQUINTINIB 1 0.0003
3 ERLOTINIB HYDROCHLORIDE 3 0.0002
4 PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE 1 0.0002
5 OSIMERTINIB 5 0.0002
6 ALECTINIB HYDROCHLORIDE 1 0.0001
7 FELODIPINE 1 0.0001
8 PEMETREXED DISODIUM 3 0.0001
9 BISACODYL SUPPOSITORIES 1 0.0001
10 BISCODYL 1 0.0001
11 BISACODYL 1 0.0001
12 SOTALOL HYDROCHLORIDE 1 0.0001
13 AXITINIB 1 0.0001
14 NIRAPARIB 1 0.0000
15 DOCETAXEL 3 0.0000
16 DOCETAXEL ANHYDROUS 3 0.0000
17 ETOPOSIDE 3 0.0000
18 RANIBIZUMAB 1 0.0000
19 LACTULOSE 1 0.0000
20 ZOLEDRONIC ACID 1 0.0000
21 ABIRATERONE ACETATE 1 0.0000
22 CARBOPLATIN 3 0.0000
23 LETROZOLE TABLETS 1 0.0000
24 LETROZOLE 1 0.0000
25 OCRELIZUMAB 1 0.0000
26 VEDOLIZUMAB 1 0.0000
27 RAMIPRIL 1 0.0000
28 APREMILAST 1 0.0000
29 DEXAMETHASONE 1.5 MG 2 0.0000
30 DEXAMETHASONE 2 0.0000
31 ALLOPURINOL 1 0.0000
32 RANITIDINE 1 0.0000
33 LENALIDOMIDE 2 0.0000
34 METFORMIN ER 500 MG 1 0.0000
35 METHOTREXATE SODIUM 1 0.0000